Literature DB >> 15316029

Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes.

Andreas Schaffner1, Charles C King, Dominik Schaer, Donald G Guiney.   

Abstract

The antimicrobial activity of a number of chemokines has recently come into focus of research about innate immunity. We have previously shown that platelet basic protein (PBP), which gives rise to several antimicrobial peptides of platelets, is also expressed in human monocytes. In the present studies, we show that exposure of human monocytes to bacteria or microbial components (lipopolysaccharide and zymosan) induces a several-fold greater expression of derivates of PBP. Also, activation of proteinase-activated receptors (PARs) by thrombin or the synthetic peptide ligand SFLLRN of PAR-1 significantly increased PBP expression, presumably on the transcriptional level, as evidenced by higher mRNA levels. Derivates of PBP appeared to reach phago-lysosomes, as higher concentration was found in latex phagosomes isolated by a flotation method. By the gel-overlay technique, two bactericidal derivatives of PBP could be visualized, which were immunoreactive with anti-PBP antibody in Western blots. By matrix-assisted laser desorption/ionization time of flight and surface-enhanced laser desorption and ionization techniques, it was confirmed that the bands corresponded to PBP derivates. After immunofixation with a monoclonal antibody to PBP, the major peptide in zymosan-stimulated monocytes was identified to correspond by molecular weight to connective tissue-activating peptide III, which has been reported to be a major antimicrobial PBP derivate also in platelets. Our observations indicate that PBP and its derivates are constituents of the antimicrobial arsenal of human monocytes. Their increased expression after exposure to microorganisms allows a rapid host response to pathogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316029     DOI: 10.1189/jlb.0404261

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Monocyte-derived CXCL7 peptides in the marrow microenvironment.

Authors:  Manoj M Pillai; Mineo Iwata; Norihiro Awaya; Lynn Graf; Beverly Torok-Storb
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

Review 2.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

3.  Gingival tissue transcriptomes in experimental gingivitis.

Authors:  Daniel Jönsson; Per Ramberg; Ryan T Demmer; Moritz Kebschull; Gunnar Dahlén; Panos N Papapanou
Journal:  J Clin Periodontol       Date:  2011-04-19       Impact factor: 8.728

4.  Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1.

Authors:  Leonard T Nguyen; Paulus H S Kwakman; David I Chan; Zhihong Liu; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

5.  CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells.

Authors:  Minghuan Yu; Richard Berk; Mary Ann Kosir
Journal:  J Oncol       Date:  2010-06-22       Impact factor: 4.375

Review 6.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

7.  RNA-Seq analysis of knocking out the neuroprotective proton-sensitive GPR68 on basal and acute ischemia-induced transcriptome changes and signaling in mouse brain.

Authors:  Guokun Zhou; Tao Wang; Xiang-Ming Zha
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.834

8.  FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells.

Authors:  Jun Yan; Qingnan Zhao; Jian Wang; Xiangjun Tian; Jing Wang; Xueqing Xia; Martina Ott; Ganesh Rao; Amy B Heimberger; Shulin Li
Journal:  Cancer Lett       Date:  2021-03-04       Impact factor: 9.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.